Avacta Therapeutics | Sustainability Performance
Engaged in biopharmaceutical development, this company focuses on creating innovative therapies, including diagnostic tools and treatments for cancers, leveraging its proprietary Affimer technology.
2006
United Kingdom
51 - 200 employees
Biotechnology
$25M - 100M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4317
Overallⓘ#566
in United Kingdomⓘ#80
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Digital emissions
Controversy level
Powered by illuminem
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.